Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.87
-0.27-2.05%
Last update: Oct 5, 3:52 AM
$12.94
-0.20-1.52%
Biohaven Ltd (BHVN) Stock Price, Quote, News & History
BHVNNYSE
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Biohaven has a consensus price target of $33.25.
The stock price for Biohaven (NYSE: BHVN) is $12.94 last updated October 5, 2026 at 3:52 AM EDT.
There are no upcoming dividends for Biohaven.
Biohaven does not have any upcoming earnings scheduled.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
